(구)글로벌 핫이슈
방사선종양학
- 2018년 11월호
[JAMA Oncol.] Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer.University of Tennessee Health Science Center / Yuefeng Wang*
- 출처
- JAMA Oncol.
- 등재일
- 2018 Sep 1
- 저널이슈번호
- 4(9):1288-1291. doi: 10.1001/jamaoncol.2018.2677.
- 내용
Abstract
Definitive pelvic chemoradiation is the standard of care for locally advanced cervical cancer.1 However, the role of definitive local radiation therapy for metastatic cervical cancer has not been established. In addition, there is growing evidence that local therapies may be associated with an increase in survival among patients with some types of metastatic cancers.2-5 In this study, we evaluated overall survival among patients with metastatic cervical cancer treated with chemotherapy alone vs pelvic chemoradiation.
“This article has a delayed release (embargo) and will be available in PMC on July 26, 2019.”
Author information
Wang Y1, Farmer M1, Izaguirre EW1, Schwartz DL1, Somer B2, Tillmanns T3, Ballo MT1.
1
Department of Radiation Oncology, West Cancer Center, University of Tennessee Health Science Center, Memphis.
2
Department of Hematology/Oncology, West Cancer Center, University of Tennessee Health Science Center, Memphis.
3
Department of Gynecologic Oncology, West Cancer Center, University of Tennessee Health Science Center, Memphis.
- 덧글달기